Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002071194 | SCV002329664 | likely benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV003228051 | SCV003924261 | uncertain significance | Weill-Marchesani 4 syndrome, recessive | 2022-10-18 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF: 0.6% [240/41282]; https://gnomad.broadinstitute.org/variant/15-100109075-A-ACTCCTT?dataset=gnomad_r3), and in ClinVar (Variation ID: 1528321). This variant represents an in-frame insertion of 2 amino acids at position 642 and is not predicted to alter the reading frame. However, the effect of this variant on the protein is unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Prevention |
RCV003968695 | SCV004788505 | likely benign | ADAMTS17-related disorder | 2024-07-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |